Myriad Genetics
MYGN
MYGN
196 hedge funds and large institutions have $828M invested in Myriad Genetics in 2020 Q2 according to their latest regulatory filings, with 30 funds opening new positions, 74 increasing their positions, 57 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
1% less ownership
Funds ownership: 98.96% → 97.95% (-1%)
22% less capital invested
Capital invested by funds: $1.06B → $828M (-$228M)
Holders
196
Holding in Top 10
–
Calls
$3.12M
Puts
$2.5M
Top Buyers
| 1 | +$18.7M | |
| 2 | +$14.6M | |
| 3 | +$9.56M | |
| 4 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$9.56M |
| 5 |
Two Sigma Investments
New York
|
+$7.19M |
Top Sellers
| 1 | -$128M | |
| 2 | -$9.47M | |
| 3 | -$4.99M | |
| 4 |
Morgan Stanley
New York
|
-$3.13M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$2.42M |